Abbott Laboratories (NY:ABT)

100.35 +2.85 (+2.93%)

Delayed Quote Updated: 1:45 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2

...

25 26 27 28 29 30 31 32 33

...

58 59 Next >

3 No-Brainer Healthcare Stocks to Buy Right Now ↗

December 15, 2023

These players have what it takes to boost your portfolio over time.

Via The Motley Fool

Where Abbott Laboratories Stands With Analysts ↗

December 13, 2023

Via Benzinga

AbbVie continues shopping spree with biotech buyout

December 12, 2023

While the diversifying AbbVie appears to be in a state of flux, there is one constant investors can depend on — the dividend.

Via MarketBeat

2 Healthcare Stocks to Buy Hand Over Fist in December ↗

December 08, 2023

These stocks are great options now -- and most any month.

Via The Motley Fool

Looking for Dividend Growth in the New Year? 3 Magnificent Stocks to Buy Now. ↗

December 07, 2023

These particular players look cheap right now.

Via The Motley Fool

$1000 Invested In Abbott Laboratories 10 Years Ago Would Be Worth This Much Today ↗

December 05, 2023

Via Benzinga

Peering Into Abbott Laboratories's Recent Short Interest ↗

December 01, 2023

Via Benzinga

Spotlight on Abbott Laboratories: Analyzing the Surge in Options Activity ↗

November 30, 2023

Via Benzinga

1 Stock Down 15% This Year to Buy and Hold Forever ↗

November 02, 2023

This stock has been delivering solid performances for a long time.

Via The Motley Fool

Here's How Much You Would Have Made Owning Abbott Laboratories Stock In The Last 10 Years ↗

November 30, 2023

Via Benzinga

Jim Cramer: Buy This Financial Stock, 'I Think They're High Quality' ↗

November 30, 2023

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Vishay Intertechnology, Inc.

Via Benzinga

Medtronic: oversold, overextended high yield reversal in play

November 22, 2023

The reversal in Medtronic has been brewing for some time but is gaining traction after strong second quarter earnings that came with improved guidance

Via MarketBeat

Magnificent 7 Take Center Stage In Hedge Fund Portfolios: Analysts Warn Of Extreme Concentration ↗

November 21, 2023

Hedge fund portfolios are intensifying their focus on technology stocks, with holdings in mega-cap tech reaching record levels.

Via Benzinga

2 No-Brainer Dividend Stocks to Buy This Week ↗

October 30, 2023

These two top-income stocks are too cheap to ignore.

Via The Motley Fool

Ozempic Might Be Helping Abbott Laboratories and DexCom Stock. Here's How. ↗

November 20, 2023

New medicines for weight loss and diabetes stand to disrupt the competitive scene.

Via The Motley Fool

Increase Prevalence of Diabetic Patients Driving Market Growth Projected to Reach $55 Billion by 2029

November 17, 2023

EQNX::TICKER_START (OTCPK:CNER),(NASDAQ:PODD),(NASDAQ:TNDM),(NYSE:LLY),(NYSE:ABT) EQNX::TICKER_END

Via FinancialNewsMedia

3 Dividend Giants to Grow Wealth no Matter What the Market Is Doing ↗

November 14, 2023

You'll be happy to own these top companies in any market environment.

Via The Motley Fool

Novo Nordisk, Eli Lilly Skid — But These Weight-Loss Results Are 'Hard To Ignore' ↗

November 13, 2023

Patients who took Wegovy for five years had a 70% reduced risk of developing diabetes.

Via Investor's Business Daily

2 No-Brainer Stocks to Buy for Forever Dividend Growth ↗

November 09, 2023

These companies generate billions of dollars in free cash flow every year.

Via The Motley Fool

2 Medical Device Companies Experiencing Strong Demand Even as Weight-Loss Drugs Rise in Popularity ↗

November 08, 2023

Investors could be making a mistake by selling off these stocks this year.

Via The Motley Fool

8 Health Care Stocks Whale Activity In Today's Session ↗

November 07, 2023

Via Benzinga

3 Dividend Kings to Buy for Royal Returns ↗

November 06, 2023

Unlock the secrets of dividend kings, the aristocrats of the stock market with unparalleled records of raising dividends yearly.

Via InvestorPlace

Looking for a Lifetime of Passive Income? 2 Top Dividend Stocks to Buy and Hold Forever ↗

November 04, 2023

Dividend stocks can cushion your portfolio in times of market trouble.

Via The Motley Fool

10 Health Care Stocks Whale Activity In Today's Session ↗

November 02, 2023

Via Benzinga

3 Dividend Stocks That Are Investor Safe Havens ↗

November 02, 2023

If there is such a thing as safe dividend stocks, these three should be at the top of your list to consider.

Via InvestorPlace

10 Health Care Stocks Whale Activity In Today's Session ↗

October 31, 2023

Via Benzinga

SLB, Abbott And 2 Other Stocks Insiders Are Selling ↗

October 31, 2023

The Nasdaq 100 closed higher by over 1% on Monday. Investors, meanwhile, focused on some notable insider trades.

Via Benzinga

MedTech Giant DexCom Spotlight Is On G7 US Launch, Analyst Forecasts 22% Revenue Gain In 2024 ↗

October 27, 2023

Oppenheimer analyst Steven Lichtman reiterated the Outperform rating on DexCom, Inc.

Via Benzinga

Got $1,000? These 2 Stocks Could Be Bargain Buys for 2023 and Beyond ↗

October 26, 2023

The market has punished them, but don't overlook these stocks.

Via The Motley Fool

Are These 3 Dividend Aristocrats Undervalued Hidden Gems?

October 25, 2023

Dividend aristocrats Caterpillar, NextEra, and Clorox have shown resilience in challenging times. These may offer opportunities as they are trading off highs.

Via MarketBeat

< Previous 1 2

...

25 26 27 28 29 30 31 32 33

...

58 59 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.